Signify Health, Inc. (NYSE: SGFY) Stock Competitors & Peer Comparison
See SGFY's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for SGFY and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| VEEV | $189.24 | -4.14% | 30.7B | 22.71 | $8.33 | N/A |
| GEHC | $62.04 | -1.26% | 28.2B | 13.61 | $4.56 | +0.23% |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | N/A |
| BTSGU | $239.04 | +3.24% | 14.4B | 216.59 | $1.11 | N/A |
| BTSG | $72.56 | +2.92% | 14.2B | 58.52 | $1.24 | N/A |
| TEM | $48.98 | +1.18% | 8.5B | -97.96 | -$0.50 | N/A |
| HQY | $97.77 | -1.12% | 8.2B | 22.84 | $4.28 | N/A |
| HNGE | $84.35 | -3.82% | 6.5B | 43.22 | $1.95 | N/A |
| RCM | $14.31 | N/A | 6B | -102.21 | -$0.14 | N/A |
Stock Comparison
Veeva Systems Inc. (NYSE: VEEV)
SGFY vs VEEV Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, VEEV has a market cap of 30.7B. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while VEEV trades at $189.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas VEEV's P/E ratio is 22.71. In terms of profitability, SGFY's ROE is -0.15%, compared to VEEV's ROE of +0.13%. Regarding short-term risk, SGFY is less volatile compared to VEEV. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check VEEV's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
SGFY vs GEHC Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, GEHC has a market cap of 28.2B. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while GEHC trades at $62.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas GEHC's P/E ratio is 13.61. In terms of profitability, SGFY's ROE is -0.15%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, SGFY is less volatile compared to GEHC. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check GEHC's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHCV)
SGFY vs GEHCV Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas GEHCV's P/E ratio is N/A. In terms of profitability, SGFY's ROE is -0.15%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, SGFY is less volatile compared to GEHCV. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check GEHCV's competition here
BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ: BTSGU)
SGFY vs BTSGU Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, BTSGU has a market cap of 14.4B. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while BTSGU trades at $239.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas BTSGU's P/E ratio is 216.59. In terms of profitability, SGFY's ROE is -0.15%, compared to BTSGU's ROE of +0.17%. Regarding short-term risk, SGFY is less volatile compared to BTSGU. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check BTSGU's competition here
BrightSpring Health Services, Inc. Common Stock (NASDAQ: BTSG)
SGFY vs BTSG Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, BTSG has a market cap of 14.2B. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while BTSG trades at $72.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas BTSG's P/E ratio is 58.52. In terms of profitability, SGFY's ROE is -0.15%, compared to BTSG's ROE of +0.17%. Regarding short-term risk, SGFY is less volatile compared to BTSG. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check BTSG's competition here
Tempus AI, Inc. (NASDAQ: TEM)
SGFY vs TEM Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, TEM has a market cap of 8.5B. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while TEM trades at $48.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas TEM's P/E ratio is -97.96. In terms of profitability, SGFY's ROE is -0.15%, compared to TEM's ROE of -0.70%. Regarding short-term risk, SGFY is less volatile compared to TEM. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check TEM's competition here
HealthEquity, Inc. (NASDAQ: HQY)
SGFY vs HQY Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, HQY has a market cap of 8.2B. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while HQY trades at $97.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas HQY's P/E ratio is 22.84. In terms of profitability, SGFY's ROE is -0.15%, compared to HQY's ROE of +0.11%. Regarding short-term risk, SGFY is less volatile compared to HQY. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check HQY's competition here
Hinge Health, Inc. (NYSE: HNGE)
SGFY vs HNGE Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, HNGE has a market cap of 6.5B. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while HNGE trades at $84.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas HNGE's P/E ratio is 43.22. In terms of profitability, SGFY's ROE is -0.15%, compared to HNGE's ROE of -1.39%. Regarding short-term risk, SGFY is less volatile compared to HNGE. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check HNGE's competition here
R1 RCM Inc. (NASDAQ: RCM)
SGFY vs RCM Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, RCM has a market cap of 6B. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas RCM's P/E ratio is -102.21. In terms of profitability, SGFY's ROE is -0.15%, compared to RCM's ROE of +0.00%. Regarding short-term risk, SGFY is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for SGFY.Check RCM's competition here
10x Genomics, Inc. (NASDAQ: TXG)
SGFY vs TXG Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, TXG has a market cap of 6B. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while TXG trades at $47.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas TXG's P/E ratio is -277.65. In terms of profitability, SGFY's ROE is -0.15%, compared to TXG's ROE of -0.03%. Regarding short-term risk, SGFY is less volatile compared to TXG. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check TXG's competition here
Doximity, Inc. (NYSE: DOCS)
SGFY vs DOCS Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, DOCS has a market cap of 3.9B. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while DOCS trades at $21.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas DOCS's P/E ratio is 13.79. In terms of profitability, SGFY's ROE is -0.15%, compared to DOCS's ROE of +0.19%. Regarding short-term risk, SGFY is less volatile compared to DOCS. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check DOCS's competition here
1Life Healthcare, Inc. (NASDAQ: ONEM)
SGFY vs ONEM Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas ONEM's P/E ratio is -7.77. In terms of profitability, SGFY's ROE is -0.15%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, SGFY is less volatile compared to ONEM. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check ONEM's competition here
Privia Health Group, Inc. (NASDAQ: PRVA)
SGFY vs PRVA Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, PRVA has a market cap of 3.3B. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while PRVA trades at $26.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas PRVA's P/E ratio is 164.44. In terms of profitability, SGFY's ROE is -0.15%, compared to PRVA's ROE of +0.03%. Regarding short-term risk, SGFY is less volatile compared to PRVA. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check PRVA's competition here
Progyny, Inc. (NASDAQ: PGNY)
SGFY vs PGNY Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, PGNY has a market cap of 2.5B. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while PGNY trades at $32.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas PGNY's P/E ratio is 23.53. In terms of profitability, SGFY's ROE is -0.15%, compared to PGNY's ROE of +0.13%. Regarding short-term risk, SGFY is less volatile compared to PGNY. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check PGNY's competition here
Heartflow, Inc. Common Stock (NASDAQ: HTFL)
SGFY vs HTFL Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, HTFL has a market cap of 2.2B. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while HTFL trades at $25.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas HTFL's P/E ratio is -12.66. In terms of profitability, SGFY's ROE is -0.15%, compared to HTFL's ROE of +8.30%. Regarding short-term risk, SGFY is less volatile compared to HTFL. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check HTFL's competition here
GeneDx Holdings Corp. (NASDAQ: WGS)
SGFY vs WGS Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, WGS has a market cap of 1.8B. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while WGS trades at $61.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas WGS's P/E ratio is 72.53. In terms of profitability, SGFY's ROE is -0.15%, compared to WGS's ROE of -0.28%. Regarding short-term risk, SGFY is less volatile compared to WGS. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check WGS's competition here
Teladoc Health, Inc. (NYSE: TDOC)
SGFY vs TDOC Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, TDOC has a market cap of 1.8B. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while TDOC trades at $9.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas TDOC's P/E ratio is -10.79. In terms of profitability, SGFY's ROE is -0.15%, compared to TDOC's ROE of -0.12%. Regarding short-term risk, SGFY is less volatile compared to TDOC. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check TDOC's competition here
NextGen Healthcare, Inc. (NASDAQ: NXGN)
SGFY vs NXGN Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas NXGN's P/E ratio is -266.00. In terms of profitability, SGFY's ROE is -0.15%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, SGFY is less volatile compared to NXGN. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check NXGN's competition here
Agiliti, Inc. (NYSE: AGTI)
SGFY vs AGTI Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas AGTI's P/E ratio is -71.79. In terms of profitability, SGFY's ROE is -0.15%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, SGFY is less volatile compared to AGTI. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check AGTI's competition here
Omada Health (NASDAQ: OMDA)
SGFY vs OMDA Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, OMDA has a market cap of 1.4B. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while OMDA trades at $22.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas OMDA's P/E ratio is 328.43. In terms of profitability, SGFY's ROE is -0.15%, compared to OMDA's ROE of -0.03%. Regarding short-term risk, SGFY is less volatile compared to OMDA. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check OMDA's competition here
Certara, Inc. (NASDAQ: CERT)
SGFY vs CERT Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, CERT has a market cap of 1.1B. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while CERT trades at $6.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas CERT's P/E ratio is 17.56. In terms of profitability, SGFY's ROE is -0.15%, compared to CERT's ROE of -0.01%. Regarding short-term risk, SGFY is less volatile compared to CERT. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check CERT's competition here
GoodRx Holdings, Inc. (NASDAQ: GDRX)
SGFY vs GDRX Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, GDRX has a market cap of 1B. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while GDRX trades at $3.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas GDRX's P/E ratio is 9.15. In terms of profitability, SGFY's ROE is -0.15%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, SGFY is less volatile compared to GDRX. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check GDRX's competition here
CareCloud, Inc. (NASDAQ: CCLDO)
SGFY vs CCLDO Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while CCLDO trades at $27.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas CCLDO's P/E ratio is N/A. In terms of profitability, SGFY's ROE is -0.15%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, SGFY is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for SGFY.Check CCLDO's competition here
HealthStream, Inc. (NASDAQ: HSTM)
SGFY vs HSTM Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, HSTM has a market cap of 813.4M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while HSTM trades at $27.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas HSTM's P/E ratio is 36.63. In terms of profitability, SGFY's ROE is -0.15%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, SGFY is less volatile compared to HSTM. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check HSTM's competition here
Evolent Health, Inc. (NYSE: EVH)
SGFY vs EVH Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, EVH has a market cap of 656.9M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while EVH trades at $5.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas EVH's P/E ratio is 584.00. In terms of profitability, SGFY's ROE is -0.15%, compared to EVH's ROE of -0.78%. Regarding short-term risk, SGFY is less volatile compared to EVH. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check EVH's competition here
Phreesia, Inc. (NYSE: PHR)
SGFY vs PHR Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, PHR has a market cap of 654.6M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while PHR trades at $10.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas PHR's P/E ratio is 37.82. In terms of profitability, SGFY's ROE is -0.15%, compared to PHR's ROE of +0.03%. Regarding short-term risk, SGFY is less volatile compared to PHR. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check PHR's competition here
MultiPlan Corporation (NYSE: MPLN-WT)
SGFY vs MPLN-WT Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, SGFY's ROE is -0.15%, compared to MPLN-WT's ROE of +2.06%. Regarding short-term risk, SGFY is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check MPLN-WT's competition here
Accolade, Inc. (NASDAQ: ACCD)
SGFY vs ACCD Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas ACCD's P/E ratio is -3.08. In terms of profitability, SGFY's ROE is -0.15%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, SGFY is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for SGFY.Check ACCD's competition here
Sharecare, Inc. (NASDAQ: SHCR)
SGFY vs SHCR Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas SHCR's P/E ratio is -3.76. In terms of profitability, SGFY's ROE is -0.15%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, SGFY is less volatile compared to SHCR. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check SHCR's competition here
GeneDx Holdings Corp. (NASDAQ: WGSWW)
SGFY vs WGSWW Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, WGSWW has a market cap of 514.5M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while WGSWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas WGSWW's P/E ratio is N/A. In terms of profitability, SGFY's ROE is -0.15%, compared to WGSWW's ROE of -0.28%. Regarding short-term risk, SGFY is less volatile compared to WGSWW. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check WGSWW's competition here
Claritev Corporation (NYSE: CTEV)
SGFY vs CTEV Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, CTEV has a market cap of 488.4M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while CTEV trades at $28.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas CTEV's P/E ratio is -2.20. In terms of profitability, SGFY's ROE is -0.15%, compared to CTEV's ROE of +2.06%. Regarding short-term risk, SGFY is less volatile compared to CTEV. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check CTEV's competition here
NRC Health (NASDAQ: NRC)
SGFY vs NRC Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, NRC has a market cap of 484.1M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while NRC trades at $21.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas NRC's P/E ratio is 26.20. In terms of profitability, SGFY's ROE is -0.15%, compared to NRC's ROE of +0.57%. Regarding short-term risk, SGFY is less volatile compared to NRC. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check NRC's competition here
SOPHiA GENETICS S.A. (NASDAQ: SOPH)
SGFY vs SOPH Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, SOPH has a market cap of 446.8M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while SOPH trades at $6.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas SOPH's P/E ratio is -12.50. In terms of profitability, SGFY's ROE is -0.15%, compared to SOPH's ROE of -1.41%. Regarding short-term risk, SGFY is less volatile compared to SOPH. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check SOPH's competition here
SomaLogic, Inc. (NASDAQ: SLGC)
SGFY vs SLGC Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas SLGC's P/E ratio is -3.04. In terms of profitability, SGFY's ROE is -0.15%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, SGFY is less volatile compared to SLGC. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check SLGC's competition here
SomaLogic, Inc. (NASDAQ: SLGCW)
SGFY vs SLGCW Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, SGFY's ROE is -0.15%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, SGFY is less volatile compared to SLGCW. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check SLGCW's competition here
TruBridge, Inc. (NASDAQ: TBRG)
SGFY vs TBRG Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while TBRG trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas TBRG's P/E ratio is 9.37. In terms of profitability, SGFY's ROE is -0.15%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, SGFY is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for SGFY.Check TBRG's competition here
MultiPlan Corporation (NYSE: MPLN)
SGFY vs MPLN Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas MPLN's P/E ratio is -0.23. In terms of profitability, SGFY's ROE is -0.15%, compared to MPLN's ROE of +2.06%. Regarding short-term risk, SGFY is less volatile compared to MPLN. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check MPLN's competition here
Simulations Plus, Inc. (NASDAQ: SLP)
SGFY vs SLP Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, SLP has a market cap of 368.7M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while SLP trades at $18.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas SLP's P/E ratio is 20.72. In terms of profitability, SGFY's ROE is -0.15%, compared to SLP's ROE of +0.06%. Regarding short-term risk, SGFY is less volatile compared to SLP. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check SLP's competition here
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC)
SGFY vs TRHC Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas TRHC's P/E ratio is -4.27. In terms of profitability, SGFY's ROE is -0.15%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, SGFY is less volatile compared to TRHC. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check TRHC's competition here
Sema4 Holdings Corp. (NASDAQ: SMFR)
SGFY vs SMFR Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas SMFR's P/E ratio is N/A. In terms of profitability, SGFY's ROE is -0.15%, compared to SMFR's ROE of -0.28%. Regarding short-term risk, SGFY is less volatile compared to SMFR. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check SMFR's competition here
So-Young International Inc. (NASDAQ: SY)
SGFY vs SY Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, SY has a market cap of 240.1M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while SY trades at $1.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas SY's P/E ratio is -5.55. In terms of profitability, SGFY's ROE is -0.15%, compared to SY's ROE of -0.16%. Regarding short-term risk, SGFY is less volatile compared to SY. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check SY's competition here
Spok Holdings, Inc. (NASDAQ: SPOK)
SGFY vs SPOK Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, SPOK has a market cap of 222.7M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while SPOK trades at $10.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas SPOK's P/E ratio is 17.77. In terms of profitability, SGFY's ROE is -0.15%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, SGFY is less volatile compared to SPOK. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check SPOK's competition here
American Well Corporation (NYSE: AMWL)
SGFY vs AMWL Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, AMWL has a market cap of 209M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while AMWL trades at $12.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas AMWL's P/E ratio is -2.41. In terms of profitability, SGFY's ROE is -0.15%, compared to AMWL's ROE of -0.35%. Regarding short-term risk, SGFY is less volatile compared to AMWL. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check AMWL's competition here
Health Catalyst, Inc. (NASDAQ: HCAT)
SGFY vs HCAT Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, HCAT has a market cap of 159.6M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while HCAT trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas HCAT's P/E ratio is 10.80. In terms of profitability, SGFY's ROE is -0.15%, compared to HCAT's ROE of -1.00%. Regarding short-term risk, SGFY is less volatile compared to HCAT. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check HCAT's competition here
Computer Programs and Systems, Inc. (NASDAQ: CPSI)
SGFY vs CPSI Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas CPSI's P/E ratio is -183.80. In terms of profitability, SGFY's ROE is -0.15%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, SGFY is less volatile compared to CPSI. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check CPSI's competition here
OptimizeRx Corp. (NASDAQ: OPRX)
SGFY vs OPRX Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, OPRX has a market cap of 125M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while OPRX trades at $6.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas OPRX's P/E ratio is 6.11. In terms of profitability, SGFY's ROE is -0.15%, compared to OPRX's ROE of +0.05%. Regarding short-term risk, SGFY is less volatile compared to OPRX. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check OPRX's competition here
Augmedix, Inc. (NASDAQ: AUGX)
SGFY vs AUGX Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas AUGX's P/E ratio is -4.99. In terms of profitability, SGFY's ROE is -0.15%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, SGFY is less volatile compared to AUGX. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check AUGX's competition here
CareCloud, Inc. (NASDAQ: CCLD)
SGFY vs CCLD Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, CCLD has a market cap of 94.8M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while CCLD trades at $2.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas CCLD's P/E ratio is 8.26. In terms of profitability, SGFY's ROE is -0.15%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, SGFY is less volatile compared to CCLD. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check CCLD's competition here
Definitive Healthcare Corp. (NASDAQ: DH)
SGFY vs DH Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, DH has a market cap of 76.5M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while DH trades at $0.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas DH's P/E ratio is 2.79. In terms of profitability, SGFY's ROE is -0.15%, compared to DH's ROE of -0.67%. Regarding short-term risk, SGFY is less volatile compared to DH. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check DH's competition here
Forian Inc. (NASDAQ: FORA)
SGFY vs FORA Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while FORA trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas FORA's P/E ratio is -24.11. In terms of profitability, SGFY's ROE is -0.15%, compared to FORA's ROE of -0.17%. Regarding short-term risk, SGFY is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for SGFY.Check FORA's competition here
CareCloud, Inc. (NASDAQ: CCLDP)
SGFY vs CCLDP Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas CCLDP's P/E ratio is N/A. In terms of profitability, SGFY's ROE is -0.15%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, SGFY is less volatile compared to CCLDP. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check CCLDP's competition here
OneMedNet Corporation (NASDAQ: ONMD)
SGFY vs ONMD Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, ONMD has a market cap of 37.2M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while ONMD trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas ONMD's P/E ratio is -4.36. In terms of profitability, SGFY's ROE is -0.15%, compared to ONMD's ROE of +0.90%. Regarding short-term risk, SGFY is less volatile compared to ONMD. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check ONMD's competition here
Science 37 Holdings, Inc. (NASDAQ: SNCE)
SGFY vs SNCE Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas SNCE's P/E ratio is -0.27. In terms of profitability, SGFY's ROE is -0.15%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, SGFY is less volatile compared to SNCE. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check SNCE's competition here
Akili, Inc. (NASDAQ: AKLI)
SGFY vs AKLI Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas AKLI's P/E ratio is -0.71. In terms of profitability, SGFY's ROE is -0.15%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, SGFY is less volatile compared to AKLI. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check AKLI's competition here
SHL Telemedicine Ltd. (NASDAQ: SHLT)
SGFY vs SHLT Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas SHLT's P/E ratio is -3.87. In terms of profitability, SGFY's ROE is -0.15%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, SGFY is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for SGFY.Check SHLT's competition here
OneMedNet Corporation (NASDAQ: ONMDW)
SGFY vs ONMDW Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, ONMDW has a market cap of 33.2M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while ONMDW trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas ONMDW's P/E ratio is N/A. In terms of profitability, SGFY's ROE is -0.15%, compared to ONMDW's ROE of +0.90%. Regarding short-term risk, SGFY is more volatile compared to ONMDW. This indicates higher risk in terms of short-term price fluctuations for SGFY.Check ONMDW's competition here
Sharecare, Inc. (NASDAQ: SHCRW)
SGFY vs SHCRW Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, SGFY's ROE is -0.15%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, SGFY is less volatile compared to SHCRW. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check SHCRW's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
SGFY vs EUDA Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, EUDA has a market cap of 26.8M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while EUDA trades at $15.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas EUDA's P/E ratio is -27.08. In terms of profitability, SGFY's ROE is -0.15%, compared to EUDA's ROE of +0.70%. Regarding short-term risk, SGFY is less volatile compared to EUDA. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check EUDA's competition here
Streamline Health Solutions, Inc. (NASDAQ: STRM)
SGFY vs STRM Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while STRM trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas STRM's P/E ratio is -2.40. In terms of profitability, SGFY's ROE is -0.15%, compared to STRM's ROE of -0.32%. Regarding short-term risk, SGFY is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for SGFY.Check STRM's competition here
Renalytix Plc (NASDAQ: RNLX)
SGFY vs RNLX Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas RNLX's P/E ratio is -0.33. In terms of profitability, SGFY's ROE is -0.15%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, SGFY is less volatile compared to RNLX. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check RNLX's competition here
MSP Recovery, Inc. (NASDAQ: LIFW)
SGFY vs LIFW Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas LIFW's P/E ratio is -0.02. In terms of profitability, SGFY's ROE is -0.15%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, SGFY is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for SGFY.Check LIFW's competition here
HeartBeam, Inc. (NASDAQ: BEATW)
SGFY vs BEATW Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, BEATW has a market cap of 18M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while BEATW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas BEATW's P/E ratio is -0.05. In terms of profitability, SGFY's ROE is -0.15%, compared to BEATW's ROE of -10.34%. Regarding short-term risk, SGFY is more volatile compared to BEATW. This indicates higher risk in terms of short-term price fluctuations for SGFY.Check BEATW's competition here
Babylon Holdings Limited (NYSE: BBLN)
SGFY vs BBLN Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas BBLN's P/E ratio is -0.04. In terms of profitability, SGFY's ROE is -0.15%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, SGFY is less volatile compared to BBLN. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check BBLN's competition here
ETAO International Co., Ltd. (NASDAQ: ETAO)
SGFY vs ETAO Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas ETAO's P/E ratio is -0.01. In terms of profitability, SGFY's ROE is -0.15%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, SGFY is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check ETAO's competition here
Bullfrog AI Holdings, Inc. Common Stock (NASDAQ: BFRG)
SGFY vs BFRG Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, BFRG has a market cap of 7.5M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while BFRG trades at $0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas BFRG's P/E ratio is -1.19. In terms of profitability, SGFY's ROE is -0.15%, compared to BFRG's ROE of -2.18%. Regarding short-term risk, SGFY is less volatile compared to BFRG. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check BFRG's competition here
Scienture Holdings, Inc. (NASDAQ: SCNX)
SGFY vs SCNX Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, SCNX has a market cap of 6M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while SCNX trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas SCNX's P/E ratio is -0.15. In terms of profitability, SGFY's ROE is -0.15%, compared to SCNX's ROE of -0.00%. Regarding short-term risk, SGFY is less volatile compared to SCNX. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check SCNX's competition here
UpHealth, Inc. (NYSE: UPH)
SGFY vs UPH Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas UPH's P/E ratio is -0.07. In terms of profitability, SGFY's ROE is -0.15%, compared to UPH's ROE of -1.05%. Regarding short-term risk, SGFY is less volatile compared to UPH. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check UPH's competition here
UpHealth, Inc. (NYSE: UPH-WT)
SGFY vs UPH-WT Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while UPH-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, SGFY's ROE is -0.15%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, SGFY is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check UPH-WT's competition here
Mangoceuticals, Inc. (NASDAQ: MGRX)
SGFY vs MGRX Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, MGRX has a market cap of 4.8M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while MGRX trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas MGRX's P/E ratio is -0.35. In terms of profitability, SGFY's ROE is -0.15%, compared to MGRX's ROE of -1.21%. Regarding short-term risk, SGFY is less volatile compared to MGRX. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check MGRX's competition here
Pear Therapeutics, Inc. (NASDAQ: PEARW)
SGFY vs PEARW Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas PEARW's P/E ratio is -0.00. In terms of profitability, SGFY's ROE is -0.15%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, SGFY is less volatile compared to PEARW. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check PEARW's competition here
Pear Therapeutics, Inc. (NASDAQ: PEAR)
SGFY vs PEAR Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas PEAR's P/E ratio is -0.08. In terms of profitability, SGFY's ROE is -0.15%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, SGFY is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check PEAR's competition here
Ontrak, Inc. (NASDAQ: OTRK)
SGFY vs OTRK Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while OTRK trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas OTRK's P/E ratio is -0.02. In terms of profitability, SGFY's ROE is -0.15%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, SGFY is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for SGFY.Check OTRK's competition here
Healthcare Triangle, Inc. (NASDAQ: HCTI)
SGFY vs HCTI Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, HCTI has a market cap of 2M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while HCTI trades at $1.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas HCTI's P/E ratio is -0.22. In terms of profitability, SGFY's ROE is -0.15%, compared to HCTI's ROE of -0.68%. Regarding short-term risk, SGFY is less volatile compared to HCTI. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check HCTI's competition here
CareMax, Inc. (NASDAQ: CMAX)
SGFY vs CMAX Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas CMAX's P/E ratio is -0.00. In terms of profitability, SGFY's ROE is -0.15%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, SGFY is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for SGFY.Check CMAX's competition here
VSee Health, Inc. (NASDAQ: VSEE)
SGFY vs VSEE Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, VSEE has a market cap of 1.5M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while VSEE trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas VSEE's P/E ratio is -0.17. In terms of profitability, SGFY's ROE is -0.15%, compared to VSEE's ROE of -115.71%. Regarding short-term risk, SGFY is less volatile compared to VSEE. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check VSEE's competition here
Aclarion, Inc. (NASDAQ: ACON)
SGFY vs ACON Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, ACON has a market cap of 1.4M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while ACON trades at $2.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas ACON's P/E ratio is -0.24. In terms of profitability, SGFY's ROE is -0.15%, compared to ACON's ROE of -0.54%. Regarding short-term risk, SGFY is less volatile compared to ACON. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check ACON's competition here
MSP Recovery, Inc. (NASDAQ: LIFWZ)
SGFY vs LIFWZ Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, SGFY's ROE is -0.15%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, SGFY is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for SGFY.Check LIFWZ's competition here
VSee Health, Inc. (NASDAQ: VSEEW)
SGFY vs VSEEW Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, VSEEW has a market cap of 1.2M. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while VSEEW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas VSEEW's P/E ratio is -0.04. In terms of profitability, SGFY's ROE is -0.15%, compared to VSEEW's ROE of -115.71%. Regarding short-term risk, SGFY is less volatile compared to VSEEW. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check VSEEW's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
SGFY vs EUDAW Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, EUDAW has a market cap of 926.3K. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while EUDAW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas EUDAW's P/E ratio is 0.03. In terms of profitability, SGFY's ROE is -0.15%, compared to EUDAW's ROE of +0.70%. Regarding short-term risk, SGFY is more volatile compared to EUDAW. This indicates higher risk in terms of short-term price fluctuations for SGFY.Check EUDAW's competition here
SCWorx Corp. (NASDAQ: WORX)
SGFY vs WORX Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, WORX has a market cap of 602.8K. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while WORX trades at $0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas WORX's P/E ratio is -0.66. In terms of profitability, SGFY's ROE is -0.15%, compared to WORX's ROE of -0.65%. Regarding short-term risk, SGFY is less volatile compared to WORX. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check WORX's competition here
MSP Recovery, Inc. (NASDAQ: MSPRZ)
SGFY vs MSPRZ Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while MSPRZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, SGFY's ROE is -0.15%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, SGFY is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check MSPRZ's competition here
Akerna Corp. (NASDAQ: KERNW)
SGFY vs KERNW Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas KERNW's P/E ratio is -0.00. In terms of profitability, SGFY's ROE is -0.15%, compared to KERNW's ROE of -0.17%. Regarding short-term risk, SGFY is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check KERNW's competition here
Akerna Corp. (NASDAQ: KERN)
SGFY vs KERN Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas KERN's P/E ratio is -0.01. In terms of profitability, SGFY's ROE is -0.15%, compared to KERN's ROE of -0.17%. Regarding short-term risk, SGFY is less volatile compared to KERN. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check KERN's competition here
MSP Recovery, Inc. (NASDAQ: LIFWW)
SGFY vs LIFWW Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas LIFWW's P/E ratio is N/A. In terms of profitability, SGFY's ROE is -0.15%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, SGFY is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for SGFY.Check LIFWW's competition here
Zhongchao Inc. (NASDAQ: ZCMD)
SGFY vs ZCMD Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, ZCMD has a market cap of 51.1K. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while ZCMD trades at $1.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas ZCMD's P/E ratio is -0.05. In terms of profitability, SGFY's ROE is -0.15%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, SGFY is less volatile compared to ZCMD. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check ZCMD's competition here
CareMax, Inc. (NASDAQ: CMAXW)
SGFY vs CMAXW Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas CMAXW's P/E ratio is N/A. In terms of profitability, SGFY's ROE is -0.15%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, SGFY is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for SGFY.Check CMAXW's competition here
Aclarion, Inc. (NASDAQ: ACONW)
SGFY vs ACONW Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, ACONW has a market cap of 11.2K. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while ACONW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas ACONW's P/E ratio is N/A. In terms of profitability, SGFY's ROE is -0.15%, compared to ACONW's ROE of -0.54%. Regarding short-term risk, SGFY is less volatile compared to ACONW. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check ACONW's competition here
Castlight Health, Inc. (NYSE: CSLT)
SGFY vs CSLT Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, CSLT has a market cap of 0. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while CSLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas CSLT's P/E ratio is -37.27. In terms of profitability, SGFY's ROE is -0.15%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, SGFY is less volatile compared to CSLT. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check CSLT's competition here
Cerner Corporation (NASDAQ: CERN)
SGFY vs CERN Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, CERN has a market cap of 0. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while CERN trades at $94.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas CERN's P/E ratio is 55.84. In terms of profitability, SGFY's ROE is -0.15%, compared to CERN's ROE of +0.14%. Regarding short-term risk, SGFY is similarly volatile compared to CERN. This indicates similar risk in terms of short-term price fluctuations for SGFY.Check CERN's competition here
Sema4 Holdings Corp. (NASDAQ: SMFRW)
SGFY vs SMFRW Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, SMFRW has a market cap of 0. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while SMFRW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas SMFRW's P/E ratio is N/A. In terms of profitability, SGFY's ROE is -0.15%, compared to SMFRW's ROE of -0.28%. Regarding short-term risk, SGFY is less volatile compared to SMFRW. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check SMFRW's competition here
Affymetrix, Inc. (NASDAQ: AFFX)
SGFY vs AFFX Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, AFFX has a market cap of 0. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while AFFX trades at $14.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas AFFX's P/E ratio is N/A. In terms of profitability, SGFY's ROE is -0.15%, compared to AFFX's ROE of +0.03%. Regarding short-term risk, SGFY is less volatile compared to AFFX. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check AFFX's competition here
CareCloud, Inc. (NASDAQ: MTBCO)
SGFY vs MTBCO Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while MTBCO trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas MTBCO's P/E ratio is N/A. In terms of profitability, SGFY's ROE is -0.15%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, SGFY is less volatile compared to MTBCO. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check MTBCO's competition here
MSP Recovery, Inc. (NASDAQ: MSPRV)
SGFY vs MSPRV Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while MSPRV trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas MSPRV's P/E ratio is N/A. In terms of profitability, SGFY's ROE is -0.15%, compared to MSPRV's ROE of N/A. Regarding short-term risk, SGFY is less volatile compared to MSPRV. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check MSPRV's competition here
CareCloud, Inc. (NASDAQ: MTBCP)
SGFY vs MTBCP Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while MTBCP trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas MTBCP's P/E ratio is N/A. In terms of profitability, SGFY's ROE is -0.15%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, SGFY is less volatile compared to MTBCP. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check MTBCP's competition here
CareCloud, Inc. (NASDAQ: MTBC)
SGFY vs MTBC Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, MTBC has a market cap of 0. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while MTBC trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas MTBC's P/E ratio is N/A. In terms of profitability, SGFY's ROE is -0.15%, compared to MTBC's ROE of +0.17%. Regarding short-term risk, SGFY is less volatile compared to MTBC. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check MTBC's competition here
Change Healthcare Inc. (NASDAQ: CHNG)
SGFY vs CHNG Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, CHNG has a market cap of 0. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while CHNG trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas CHNG's P/E ratio is -152.72. In terms of profitability, SGFY's ROE is -0.15%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, SGFY is less volatile compared to CHNG. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check CHNG's competition here
Convey Health Solutions Holdings, Inc. (NYSE: CNVY)
SGFY vs CNVY Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, CNVY has a market cap of 0. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while CNVY trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas CNVY's P/E ratio is -71.50. In terms of profitability, SGFY's ROE is -0.15%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, SGFY is less volatile compared to CNVY. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check CNVY's competition here
IMS Health Holdings, Inc. (NYSE: IMS)
SGFY vs IMS Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, IMS has a market cap of 0. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while IMS trades at $31.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas IMS's P/E ratio is N/A. In terms of profitability, SGFY's ROE is -0.15%, compared to IMS's ROE of +0.27%. Regarding short-term risk, SGFY is less volatile compared to IMS. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check IMS's competition here
Alkuri Global Acquisition Corp. (NASDAQ: KURIU)
SGFY vs KURIU Comparison July 2026
Signify Health, Inc. (NYSE: SGFY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGFY stands at 8.9B. In comparison, KURIU has a market cap of 0. Regarding current trading prices, SGFY is priced at $30.49 on the NYSE, while KURIU trades at $9.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGFY currently has a P/E ratio of 70.91, whereas KURIU's P/E ratio is N/A. In terms of profitability, SGFY's ROE is -0.15%, compared to KURIU's ROE of +1.06%. Regarding short-term risk, SGFY is less volatile compared to KURIU. This indicates lower risk in terms of short-term price fluctuations for SGFY.Check KURIU's competition here